Freedom Media

Ok it's a fake but it's still funny AF

Karen is a WEF stooge, gets all her boosters and loves eating crickets.

In COVID hearing, #Pfizer director admits: #vaccine was never tested on preventing transmission. "Get vaccinated for others" was always a lie. The only purpose of the #COVID passport: forcing people to get vaccinated. The world needs to know. Share this video!

The Saudi Ambassador in Cairo keels over in the middle of a speech. Probably the bloody climate change or maybe giving speeches now causes heart attacks as well #SafeAndEffective

Tedros calls on all social media platforms to work with the WHO to counter #monkeypox "disinformation." Covering Vaxx-induced shingles will be their next thing

Sick of inflation of mandates. Sick of the lies and corruption. Are you sick of mismanagement and mishandling of your government. You are not alone, there are billions of us

It's no more than any of them deserve

This needs to go viral

The filming crew of IA "Arbelet" was the first to visit the territory where the OSCE mission in Mariupol was located. Among other valuable finds, they found two mortar positions, equipped directly near the mission's administrative building. The mortars themselves and their ammunition are of Italian origin, as evidenced by the markings. Another noteworthy fact: the last delivery of the Italian BC is dated March 11, 2022.

They created them, we usurped them. A montage of @edthetechie's vlandles all in one place

Flag wavers should really do their research

Examples Of Technology Being Used To Alter What We See.

Watch it and tell us we're wrong

Follow the evidence, wherever it leads https://www.youtube.com/watch?v=rfyOihhAD4A Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database Purpose To evaluate the difference in mortality, Patients treated with ivermectin Patients treated with remdesivir 44 healthcare organizations and 68 million patients from US, January 1, 2020 and July 11, 2021 Methods & Materials Retrospectively identified diagnosed adults Recorded use of ivermectin, but not remdesivir Recorded use of remdesivir, but not ivermectin Controlled for, comorbidities, and treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use. Primary outcome assessed, mortality Sith significance assessed at p less than 0.05. Result 41,608 patients who had COVID-19 Treated with ivermectin n = 1,072 Treated with remdesivir n = 40,536 Ivermectin was associated with reduced mortality vs remdesivir OR 0.308 p less than 0.0001. Conclusion Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir. In the future, if more publications are published with the similar result to the current analyses, the certainty of evidence will increase. Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching (Brazil) https://www.cureus.com/articles/82162... Background Ivermectin has demonstrated different mechanisms of action, coronavirus infection and COVID-19-related comorbidities. Prophylaxis combined with the known safety profile of ivermectin Study to evaluate the impact of regular ivermectin use on subsequent COVID-19 infection and mortality rates. Prospective, July 2020 and December 2020 Inviting the entire population of Itajaí to a medical visit to enroll in the program, ivermectin was offered as an optional treatment to be taken for two consecutive days every 15 days at a dose of 0.2 mg/kg/day. Study analysis consisted of comparing ivermectin users with non-users using cohorts Results 223,128 citizens of Itajaí considered 159,561 included in the analysis 113,845 (71.3%) regular ivermectin users 45,716 (23.3%) non-users Of these 4,311 ivermectin users were infected, (3.7% infection rate) 3,034 non-users (6.6% infection rate) A 44% reduction in COVID-19 infection rate Risk ratio (RR), 0.56 The regular use of ivermectin led to a 68% reduction in COVID-19 mortality Deaths 25 (0.8%) deaths in the ivermectin group 79 (2.6%) among ivermectin non-users RR, 0.32 p less than 0.0001 When adjusted for residual variables, reduction in mortality rate was 70% There was a 56% reduction in hospitalization rate 44 in the ivermectin group 99 in non ivermectin users After adjustment for residual variables, reduction in hospitalization rate was 67% p less than 0.0001 Conclusion In this large study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.

Klaus Schwab welcomes the public to his World Economic Forum. Let's go tell him what our opinion of the World Economic Forum really is. The puppets aren't listening, take our voices their master. Everyone welcome worldwide. April 3rd 2022. Join us https://t.me/ourWFF

This one goes out to everyone in Canada and around the world who are standing against the darkness. We are one.

What you thought the Mounties were like and what they are really like

You might want to sell those Moderna shares while you still can. Wall Street isn't happy

WATCH — Trudeau's justice minister says that being “pro-Trump” is a factor that will decide if your bank account is seized under their Emergency Orders.

This is genius and needs to go viral